Gene · 7155
Papers2,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,315
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SMC5 Plays Independent Roles in Congenital Heart Disease and Neurodevelopmental Disability. | Int J Mol Sci | 2023 | 38203602 | PubTator, text mining | PubMed |
| Noval ceRNA axis-mediated high expression of TOP2A correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma. | Transl Cancer Res | 2023 | 38193002 | PubTator, text mining | PubMed |
| Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention. | Front Cardiovasc Med | 2023 | 38173817 | PubTator, text mining | PubMed |
| AMGDTI: drug-target interaction prediction based on adaptive meta-graph learning in heterogeneous network. | Brief Bioinform | 2023 | 38145949 | PubTator, text mining | PubMed |
| Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity. | Front Pharmacol | 2023 | 38143497 | PubTator, text mining | PubMed |
| Podophyllotoxin: Recent Advances in the Development of Hybridization Strategies to Enhance Its Antitumoral Profile. | Pharmaceutics | 2023 | 38140069 | PubTator, text mining | PubMed |
| Circulating Biomarkers for Monitoring Chemotherapy-Induced Cardiotoxicity in Children. | Pharmaceutics | 2023 | 38140053 | PubTator, text mining | PubMed |
| Heterozygous Knockout of ARID4B Using CRISPR/Cas9 Attenuates Some Aggressive Phenotypes in a Breast Cancer Cell Line. | Genes (Basel) | 2023 | 38137006 | PubTator, text mining | PubMed |
| A CircRNA-miRNA-mRNA Network for Exploring Doxorubicin- and Myocet-Induced Cardiotoxicity in a Translational Porcine Model. | Biomolecules | 2023 | 38136582 | PubTator, text mining | PubMed |
| HER2-Targeted Therapy-From Pathophysiology to Clinical Manifestation: A Narrative Review. | J Cardiovasc Dev Dis | 2023 | 38132657 | PubTator, text mining | PubMed |
| Spinal Ependymomas: An Updated WHO Classification and a Narrative Review. | Cureus | 2023 | 38125233 | PubTator, text mining | PubMed |
| Mobile circular DNAs regulating memory and communication in CNS neurons. | Front Mol Neurosci | 2023 | 38125007 | PubTator, text mining | PubMed |
| Supervised exercise training in patients with cancer during anthracycline-based chemotherapy to mitigate cardiotoxicity: a randomized-controlled-trial. | Front Cardiovasc Med | 2023 | 38111886 | PubTator, text mining | PubMed |
| Induction of double-strand breaks with the non-steroidal androgen receptor ligand flutamide in patients on androgen suppression: a study protocol for a randomized, double-blind prospective trial. | Trials | 2023 | 38104131 | PubTator, text mining | PubMed |
| ERK2-topoisomerase II regulatory axis is important for gene activation in immediate early genes. | Nat Commun | 2023 | 38097570 | PubTator, text mining | PubMed |
| Maf1 controls retinal neuron number by both RNA Pol III- and Pol II-dependent mechanisms. | iScience | 2023 | 38089586 | PubTator, text mining | PubMed |
| Symphony in the crowd: Key genetic alterations in prostate cancer. | Cancer Innov | 2023 | 38089408 | PubTator, text mining | PubMed |
| A Review on Probable Causes of Cardiotoxicity Caused by Common Cancer Drugs and the Role of Traditional Chinese Medicine in Prevention and Treatment. | Pharmgenomics Pers Med | 2023 | 38084311 | PubTator, text mining | PubMed |
| The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer. | Nat Commun | 2023 | 38057321 | PubTator, text mining | PubMed |
| RAD54L2 counters TOP2-DNA adducts to promote genome stability. | Sci Adv | 2023 | 38055822 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7155/papers?page=8